Fund Aims To Close Science's Gender Gap

Although a gender imbalance in the physical sciences has been evident for years, few private foundations have allocated significant sums to encourage the participation of women in hard science disciplines. But the Henry Luce Foundation’s newly established Clare Boothe Luce Fund has taken the initiative in attempting to rectify the problem by setting aside a $70 million endowment specifically to provide professorships, fellowships, and scholarships for women scientists in higher education.

Written byBarbara Spector
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Although a gender imbalance in the physical sciences has been evident for years, few private foundations have allocated significant sums to encourage the participation of women in hard science disciplines. But the Henry Luce Foundation’s newly established Clare Boothe Luce Fund has taken the initiative in attempting to rectify the problem by setting aside a $70 million endowment specifically to provide professorships, fellowships, and scholarships for women scientists in higher education. The long-range aim of the fund is to “increase the number of women who choose science majors,” says Henry Luce III, stepson of Mrs. Luce and president of the Luce Foundation.

While Mrs. Luce, wife of Time Inc. founder Henry R. Luce, was a United States congresswoman, playwright, editor of Vanity Fair, and U.S. ambassador to Italy, she was never a scientist. However, her stepson says, she perceived that science “is the area where women are least represented and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies